AU2002212741A1 - High-density lipoprotein-cholesterol level elevating agent - Google Patents

High-density lipoprotein-cholesterol level elevating agent

Info

Publication number
AU2002212741A1
AU2002212741A1 AU2002212741A AU1274102A AU2002212741A1 AU 2002212741 A1 AU2002212741 A1 AU 2002212741A1 AU 2002212741 A AU2002212741 A AU 2002212741A AU 1274102 A AU1274102 A AU 1274102A AU 2002212741 A1 AU2002212741 A1 AU 2002212741A1
Authority
AU
Australia
Prior art keywords
density lipoprotein
cholesterol level
elevating agent
level elevating
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212741A
Inventor
Yuichiro Amano
Masakuni Kori
Tomoyuki Nishimoto
Ryuichi Tozawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2002212741A1 publication Critical patent/AU2002212741A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
AU2002212741A 2000-11-09 2001-11-09 High-density lipoprotein-cholesterol level elevating agent Abandoned AU2002212741A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-342607 2000-09-11
JP2000342607 2000-11-09
PCT/JP2001/009802 WO2002038180A1 (en) 2000-11-09 2001-11-09 High-density lipoprotein-cholesterol level elevating agent

Publications (1)

Publication Number Publication Date
AU2002212741A1 true AU2002212741A1 (en) 2002-05-21

Family

ID=18817124

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212741A Abandoned AU2002212741A1 (en) 2000-11-09 2001-11-09 High-density lipoprotein-cholesterol level elevating agent

Country Status (7)

Country Link
US (2) US20040063750A1 (en)
EP (1) EP1332763A4 (en)
KR (1) KR20030048465A (en)
CN (1) CN1473053A (en)
AU (1) AU2002212741A1 (en)
CA (1) CA2428669A1 (en)
WO (1) WO2002038180A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1097928B1 (en) * 1995-09-13 2008-07-16 Takeda Pharmaceutical Company Limited 5-(2,3-Dialkoxyphenyl)-4,1-benzoxazepin-2-ones as anti-hyperlipidemics
EP1407782A4 (en) * 2001-06-28 2004-10-20 Takeda Chemical Industries Ltd Preventives/remedies for organ functional disorders and organ dysfunction
WO2004064865A1 (en) * 2003-01-17 2004-08-05 Takeda Pharmaceutical Company Limited Skeletal muscle protecting agent
TW200510356A (en) * 2003-08-01 2005-03-16 Takeda Chemical Industries Ltd Benzoxaepine compounds
WO2005065715A1 (en) * 2003-12-25 2005-07-21 Takeda Pharmaceutical Company Limited Method of improving suitability for granulation
AU2005252111A1 (en) * 2004-06-11 2005-12-22 Takeda Pharmaceutical Company Limited Highly selective novel amidation method
US20090118255A1 (en) * 2004-08-09 2009-05-07 Takeda Pharmaceutical Company Limited Crp Lowering Agent
TW200714280A (en) * 2005-06-01 2007-04-16 Takeda Pharmaceuticals Co Novel method of treating hyperlipidemia
BRPI0811204A8 (en) * 2007-05-10 2015-09-22 Bristol Myers Squibb Co TETRA-HYDROIBENZO-1,4-DIAZEPINES SUBSTITUTED BY ARYL AND HETEROARYL AND THE USE OF THEM TO BLOCK NOREPINEPHRINE, DOPAMINE AND SEROTONIN REUPPATION

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096923A (en) * 1990-03-21 1992-03-17 Merck & Co., Inc. Novel squalene synthetase inhibitors
US5312814A (en) * 1992-12-09 1994-05-17 Bristol-Myers Squibb Co. α-phosphonocarboxylate squalene synthetase inhibitors
US5447922A (en) * 1994-08-24 1995-09-05 Bristol-Myers Squibb Company α-phosphonosulfinic squalene synthetase inhibitors
TW401301B (en) * 1994-10-07 2000-08-11 Takeda Chemical Industries Ltd Antihypertriglyceridemic composition
CA2159850A1 (en) * 1994-11-03 1996-05-04 Yadagiri Pendri Phosphonosulfonate squalene synthetase inhibitor salts and method
US5618964A (en) * 1995-06-07 1997-04-08 Bristol-Myers Squibb Company Prodrug esters of phosphonosulfonate squalene synthetase inhibitors and method
EP1097928B1 (en) * 1995-09-13 2008-07-16 Takeda Pharmaceutical Company Limited 5-(2,3-Dialkoxyphenyl)-4,1-benzoxazepin-2-ones as anti-hyperlipidemics
EP0862562B1 (en) * 1995-09-13 2001-07-04 Takeda Chemical Industries, Ltd. Benzoxazepine compounds, their production and use as lipid lowering agents
JPH0987260A (en) * 1995-09-27 1997-03-31 Takeda Chem Ind Ltd Condensed ring compound and its use
CN1437587A (en) * 2000-06-23 2003-08-20 武田药品工业株式会社 Benzoxazepinones and their use as squalene synthase inhibitors

Also Published As

Publication number Publication date
WO2002038180A1 (en) 2002-05-16
CN1473053A (en) 2004-02-04
CA2428669A1 (en) 2002-05-16
EP1332763A1 (en) 2003-08-06
US20040063750A1 (en) 2004-04-01
EP1332763A4 (en) 2007-03-14
US20080058310A1 (en) 2008-03-06
KR20030048465A (en) 2003-06-19

Similar Documents

Publication Publication Date Title
HUP0400689A3 (en) Abca-1 level elevating compounds
AU2001237041A1 (en) Kinase inhibitors
AU2001258771A1 (en) -secretase inhibitors
AU4882101A (en) Mmp-12 inhibitors
AU2002311944A1 (en) Retrieval catheter
AU2001271918A1 (en) Localized access
AU2001256769A1 (en) Triazole derivatives
AU2001292120A1 (en) Urinary catheters
AU2001234088A1 (en) TNF-alpha inhibitors
AU2001280598A1 (en) Anti-occlusion catheter
AU2001285750A1 (en) Urokinase inhibitors
EP1151667A3 (en) Plant-activating agent
AU5248800A (en) Fading inhibitors
AU2000223275A1 (en) Novel triazole derivatives
AU2002222627A1 (en) Tak1 inhibitors
AU2002212741A1 (en) High-density lipoprotein-cholesterol level elevating agent
AU2001258841A1 (en) Heterocyclic compounds
AU3235100A (en) Prothease inhibitors
AU2001232245A1 (en) Tnf- alpha inhibitors
AU2001267589A1 (en) Cycloalkyl - or cycloalkylmethyl-substituted 6-phenylphenanthridines
AU2001225524A1 (en) Elevating gate
AU2001273389A1 (en) Wireless turntable
AU6164800A (en) Level sensor-switch
AU2001295815A1 (en) Multiple purpose catheter
AU2001284194A1 (en) Storage facility